Mary Disis
Medical Oncology · Seattle, WANPI 1033294830
Payments from drug & device makers
What this record shows
That places this record below the midpoint for medical oncology clinicians in WA, where the typical reported total is $2,355.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,187,567in research payments, 2019–2025
Across 69 payments — averaging $17,211 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$580K
- Johnson & Johnson$394K
- Bavarian Nordic A/s$135K
- Pfizer$54K
- EMD Serono, Inc.$25K
How this compares
$0 in reported general payments places this provider in the 5th percentile of 162 medical oncology providers in Washington.
Other medical oncology in Seattle
- Bart ScottSeattle$1.3M
- Petros GrivasSeattle$628K
- Vijayakrishna GadiSeattle$573K
- Evan YuSeattle$296K
- Siddhartha DevarakondaSeattle$215K
- David MaloneySeattle$150K
- Gary LymanSeattle$130K
- Rafic FarahSeattle$114K
- Laura ChowSeattle$114K
- Shailender BhatiaSeattle$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.